Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes ...
The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.
In 2025, MG will also begin offering new models from its freshly introduced ‘Select’ dealerships that has been conceptualised for its premium range of cars Morris Garages, commonly known as MG ...
The Healthy on MSN4d
FDA Announcement: The First Generic GLP-1 Shot Has Just Been ApprovedThis may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from the pricier kind.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback